Cargando…

New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes

The main objective of the MACIVIVA European consortium was to develop new Good Manufacturing Practice pilot lines for manufacturing thermostable vaccines with stabilized antigens on influenza virosomes as enveloped virus-like particles. The HIV-1 gp41-derived antigens anchored in the virosome membra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amacker, Mario, Smardon, Charli, Mason, Laura, Sorrell, Jack, Jeffery, Kirk, Adler, Michael, Bhoelan, Farien, Belova, Olga, Spengler, Mark, Punnamoottil, Beena, Schwaller, Markus, Bonduelle, Olivia, Combadière, Behazine, Stegmann, Toon, Naylor, Andrew, Johnson, Richard, Wong, Desmond, Fleury, Sylvain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235025/ https://www.ncbi.nlm.nih.gov/pubmed/32435515 http://dx.doi.org/10.1038/s41541-020-0190-9

Ejemplares similares

Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate
por: Fernandes, Bárbara, et al.
Publicado: (2022)

A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge
por: Koopman, Gerrit, et al.
Publicado: (2023)

Enhanced HPV16 E6/E7(+) tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides
por: Stegmann, Toon, et al.
Publicado: (2023)

A novel inactivated virus system (InViS) for a fast and inexpensive assessment of viral disintegration
por: Furer, Lea A., et al.
Publicado: (2022)

Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability
por: Lederhofer, J., et al.
Publicado: (2018)

Strategies for Immunomonitoring after Vaccination and during Infection
por: Adam, Lucille, et al.
Publicado: (2021)

P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes
por: Bomsel, M, et al.
Publicado: (2009)

Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice
por: Kamphuis, Tobias, et al.
Publicado: (2012)

Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models
por: Tamborrini, Marco, et al.
Publicado: (2020)

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes
por: Leroux-Roels, Geert, et al.
Publicado: (2013)

Original Encounter with Antigen Determines Antigen-Presenting Cell Imprinting of the Quality of the Immune Response in Mice
por: Abadie, Valérie, et al.
Publicado: (2009)

A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats
por: Kamphuis, Tobias, et al.
Publicado: (2013)

Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate
por: Fernandes, Bárbara, et al.
Publicado: (2022)

Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations
por: Tamborrini, Marco, et al.
Publicado: (2011)

Virosome: An engineered virus for vaccine delivery
por: Ali, Hasan, et al.
Publicado: (2023)

A Triple Co-Culture Model of the Human Respiratory Tract to Study Immune-Modulatory Effects of Liposomes and Virosomes
por: Blom, Rebecca A. M., et al.
Publicado: (2016)

New challenges in modern vaccinology
por: Centlivre, Mireille, et al.
Publicado: (2015)

Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP
por: Pedersen, Gabriel Kristian, et al.
Publicado: (2011)

Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4(+) T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen
por: Blom, Rebecca A. M., et al.
Publicado: (2017)

A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike
por: van der Velden, Yme U., et al.
Publicado: (2022)

CD8(+)PD-L1(+)CXCR3(+) polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2–infected patients
por: Adam, Lucille, et al.
Publicado: (2021)

Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges
por: Lakhashe, Samir K., et al.
Publicado: (2022)

Mosaic hoxb4a Neuronal Pleiotropism in Zebrafish Caudal Hindbrain
por: Ma, Leung-Hang, et al.
Publicado: (2009)

Virosome Presents Multimodel Cancer Therapy without Viral Replication
por: Saga, Kotaro, et al.
Publicado: (2013)

Peptide-Based Vaccination for Antibody Responses Against HIV
por: Combadière, Behazine, et al.
Publicado: (2019)

LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications
por: Combadière, Behazine, et al.
Publicado: (2021)

Reconstruction of H(3)N(2) influenza virus based virosome in-vitro
por: Abdoli, Asghar, et al.
Publicado: (2013)

Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine
por: Fonseca, Francisco Noé, et al.
Publicado: (2023)

Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial
por: Combadière, Behazine, et al.
Publicado: (2010)

Dichotomy in Neutralizing Antibody Induction to Peptide-Conjugated Vaccine in Squalene Emulsion Contrast With Aluminum Hydroxide Formulation
por: Bonduelle, Olivia, et al.
Publicado: (2022)

Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine
por: Alicino, Cristiano, et al.
Publicado: (2014)

Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
por: Cox, Freek, et al.
Publicado: (2015)

Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein
por: Gargett, Tessa, et al.
Publicado: (2014)

Development, Biological Characterization, and Immunological Evaluation of Virosome Vaccine against Newcastle Disease in Pakistan
por: Rasool, Muhammad Hidayat, et al.
Publicado: (2021)

A polyvalent virosomal influenza vaccine induces broad cellular and humoral immunity in pigs
por: Haach, Vanessa, et al.
Publicado: (2023)

Selective Induction of Apoptosis in Mature T Lymphocytes by Variant T Cell Receptor Ligands
por: Combadière, Behazine, et al.
Publicado: (1998)

Construction of influenza virosome from influenza A H1N1 PR8
por: Noori, Mehri, et al.
Publicado: (2011)

Influenza T-cell Epitope-Loaded Virosomes Adjuvanted with CpG as a Potential Influenza Vaccine
por: Soema, Peter C., et al.
Publicado: (2014)

Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
por: Thompson, Fiona M., et al.
Publicado: (2008)

Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review
por: Asadi, Khatereh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qns3en70u4mktm6nbnu048mfv5